Céline Amara

547 total citations
12 papers, 249 citations indexed

About

Céline Amara is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Céline Amara has authored 12 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Céline Amara's work include CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Immune Cell Function and Interaction (3 papers). Céline Amara is often cited by papers focused on CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Immune Cell Function and Interaction (3 papers). Céline Amara collaborates with scholars based in France, United States and Germany. Céline Amara's co-authors include Torsten Tonn, Dorotheé von Laer, Reinhard Henschler, Hermann Kreyenberg, Zyrafete Kuçi, Peter Bader, T. Klingebiel, Eva Rettinger, Erika Deak and Manuel Grez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Nature Biotechnology.

In The Last Decade

Céline Amara

9 papers receiving 243 citations

Peers

Countries citing papers authored by Céline Amara

Since Specialization

Citations

This map shows the geographic impact of Céline Amara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Amara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Amara more than expected).

Fields of papers citing papers by Céline Amara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Amara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Amara. The network helps show where Céline Amara may publish in the future.

Co-authorship network of co-authors of Céline Amara

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Amara. A scholar is included among the top collaborators of Céline Amara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Amara. Céline Amara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile 2024 ·Blood Advances ·Zhihong Zeng, (unknown), (unknown), (unknown), S. Guérif, Veronique De Brabandere, Céline Amara, Eline Dejonckheere, Angéla Virone-Oddos, Marielle Chiron, Marina Konopleva, Mélissa Dullaers	17
2	Abstract 2118: SGN-CEACAM5C/SAR445953, a novel topoisomerase I inhibitor antibody-drug conjugate targeting CEACAM5, has potent anti-tumor activity in CRC, PDAC, GC and lung cancer tumor models 2024 ·Cancer Research ·(unknown), Céline Nicolazzi, (unknown), Céline Amara, Astrid Clarke, (unknown), (unknown), Valeria R. Fantin, Marielle Chiron, Stéphanie Decary	0
3	Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123 2023 ·Nature Biotechnology ·Laurent Gauthier, Angéla Virone-Oddos, Jochen Beninga, Benjamín Rossi, Céline Nicolazzi, Céline Amara, (unknown), Nicolas Gourdin, (unknown), (unknown), (unknown), (unknown), Gwendoline Grondin, (unknown), Anne-Laure Bauchet, Ariane Morel, Yannis Morel, Marielle Chiron, Éric Vivier	62
4	The Novel Trifunctional Anti-BCMA NK Cell Engager SAR'514 Has Potent in-Vitro and in-Vivo Anti-Myeloma Effect through Dual NK Cell Engagement 2022 ·Blood ·(unknown), Laurent Gauthier, Jochen Beninga, Benjamín Rossi, Nicolas Gourdin, (unknown), Céline Amara, (unknown), (unknown), (unknown), (unknown), Emmanuelle Ménoret, Catherine Pellat‐Deceunynck, Philippe Moreau, Yannis Morel, Marielle Chiron, Angéla Virone-Oddos, Éric Vivier	5
5	Abstract 2909: CD123-CODV-TCE bispecific T-cell engager for acute myeloid leukemia (AML): Activity on primary AML and safety in non-human primates 2022 ·Cancer Research ·(unknown), (unknown), (unknown), Anne-Laure Bauchet, (unknown), Céline Amara, (unknown), (unknown), Maxime Moulard, Marco Meloni, Mélissa Dullaers, Marielle Chiron, Angéla Virone-Oddos	0
6	852 Trifunctional NKp46/CD16a-NK cell engager targeting CD123 overcomes acute myeloid leukemia resistance to ADCC 2021 ·SHILAP Revista de lepidopterología ·Laurent Gauthier, Angéla Virone-Oddos, Jochen Beninga, Benjamín Rossi, Céline Nicolazzi, Céline Amara, (unknown), Nicolas Gourdin, (unknown), (unknown), (unknown), Gwendoline Grondin, (unknown), Anne-Laure Bauchet, Ariane Morel, Yannis Morel, Marielle Chiron, Éric Vivier	2
7	Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates 2017 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Céline Amara, Céline Nicolazzi, (unknown), (unknown), (unknown), (unknown), Christine Veyrat‐Follet	8
8	Abstract LB-053: Towards new cryptophycins as promising payloads for ADC 2016 ·Cancer Research ·(unknown), Hervé Bouchard, François Clerc, Jidong Zhang, Pierre-Yves Abécassis, Céline Amara, (unknown), (unknown), Céline Nicolazzi, (unknown), Olivier Pasquier, (unknown), Pierre‐François Berne, (unknown), (unknown), Sylvain Huille, Christophe Henry, Anne‐Marie Lefebvre, (unknown)	2
9	Abstract B145: PK/PD evaluation of an anti-CEACAM5 antibody drug conjugate, in a colon patient-derived-xenografted mice model 2015 ·Molecular Cancer Therapeutics ·Christophe Henry, Céline Nicolazzi, Céline Amara, Anne‐Marie Lefebvre, (unknown), (unknown), (unknown), (unknown), (unknown), Stéphanie Decary, Cécile Combeau, Pierre‐François Berne, Souâd Naimi, Marielle Chiron, Véronique Blanc	0
10	In Vivo Testing of Drug-Linker Stability 2013 ·Methods in molecular biology ·Pierre-Yves Abécassis, Céline Amara	3
11	CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties 2010 ·Haematologica ·Selim Kuçi, Zyrafete Kuçi, Hermann Kreyenberg, Erika Deak, (unknown), Sabine Huenecke, Céline Amara, (unknown), Eva Rettinger, Manuel Grez, Ulrike Koehl, Hatixhe Latifi-Pupovci, Reinhard Henschler, Torsten Tonn, Dorotheé von Laer, T. Klingebiel, Peter Bader	142
12	Design of potent and selective GSK3β inhibitors with acceptable safety profile and pharmacokinetics 2010 ·Bioorganic & Medicinal Chemistry Letters ·Dominique Lesuisse, Gilles Tiraboschi, (unknown), Pierre-Yves Abécassis, (unknown), (unknown), Frank Halley, (unknown), (unknown), Alain Chevalier, Dominique Quarteronet, Marie‐Claude Burgevin, Céline Amara, Philìppe Bertrand, Thomas Rooney	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact